Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility

Experimental Neurology

Volumn 168, Issue 1, 2001, Pages 116-122

  Hofele, Katja ^a   Sedelis, Marco ^a   Auburger, Georg W ^a   Morgan, Sarah ^a   Huston, Joseph P ^a   Schwarting, Rainer K W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BRAIN MONOAMINE; DOPAMINE; MONOPHENOL MONOOXYGENASE; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ALBINISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL COUNT; CONGENIC STRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; ENZYME ACTIVITY; MALE; MOUSE; NEOSTRIATUM; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REARING; STRAIN DIFFERENCE; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

EID: 0035127181     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7588     Document Type: Article

References (35)

1. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
2. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
3. Selectivity of the parkinsonian neurotoxin MPTP: Toxic metabolite MPP+ selectively binds to neuromelanin
4. Neuromelanin: A role in MPTP-induced toxicity
5. Genetic factors in neurotoxicology and neuropharmacology: A critical evaluation of the use of genetics as a research tool
6. MPTP-induced behavioural and biochemical deficits: A parametric analysis
7. Dopamine transporter is required for in vivo MPTP neurotoxicity: Evidence from mice lacking the transporter
8. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice
9. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
10. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse
11. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice
12. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in swiss-webster mice from different sources
13. The acute effect on levels of catecholamines and metabolites in brain, of a single dose of MPTP in 8 strains of mice
14. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: Role of BDNF gene expression
15. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways
16. Activation and lateralization of sensorimotor field for perioral biting reflex by intranigral GABA agonist and by systemic apomorphine in the rat
17. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
18. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey
19. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
20. Base substitution at different alternative splice donor sites of the tyrosinase gene in murine albinism
21. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice
22. Mechanisms of MPTP toxicity
23. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier
24. Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase
25. Low dopamine transporter mRNA levels in midbrain regions containing calbindin
26. Short-term effects of ether, equithesin and droperidol/fentanyl on catecholamine and indolamine metabolism in the brain of the rat
27. Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease
28. MPTP susceptibility in the mouse: Behavioral, neurochemical, and histological analysis of gender and strain differences
29. Handedness in rats: Blockade of reaching behavior by unilateral 6-OHDA injections into substantia nigra and caudate nucleus
30. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice
31. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice: Comparison with three other strains of mice
32. Cytotoxic effect of 1-methyl-4-phenylpyridinium ion on human melanoma cell lines, HMV-II and SK-MEL-44, is dependent on the melanin contents and caused by inhibition of mitochondrial electron transport
33. Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice
34. Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice